MRI-targeted or standard biopsy for prostate-cancer diagnosis
Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence i...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 19, 2018
|
| In: |
The New England journal of medicine
Year: 2018, Jahrgang: 378, Pages: 1767-1777 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJMoa1801993 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1801993 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1801993 
|
| Verfasserangaben: | Veeru Kasivisvanathan, Antti S. Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G. Hindley, Monique J. Roobol, Scott Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert M. Villeirs, Jaspal Virdi, Silvan Boxler, Grégoire Robert, Paras B. Singh, Wulphert Venderink, Boris A. Hadaschik, Alain Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter Pinto, Inderbir Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman R. Williams, Chris Brew-Graves, Jonathan Deeks, Yemisi Takwoingi, Mark Emberton, and Caroline M. Moore |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694604020 | ||
| 003 | DE-627 | ||
| 005 | 20230427095037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200415s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMoa1801993 |2 doi | |
| 035 | |a (DE-627)1694604020 | ||
| 035 | |a (DE-599)KXP1694604020 | ||
| 035 | |a (OCoLC)1341315148 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kasivisvanathan, Veeru |e VerfasserIn |0 (DE-588)1208340522 |0 (DE-627)1694605205 |4 aut | |
| 245 | 1 | 0 | |a MRI-targeted or standard biopsy for prostate-cancer diagnosis |c Veeru Kasivisvanathan, Antti S. Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G. Hindley, Monique J. Roobol, Scott Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert M. Villeirs, Jaspal Virdi, Silvan Boxler, Grégoire Robert, Paras B. Singh, Wulphert Venderink, Boris A. Hadaschik, Alain Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter Pinto, Inderbir Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman R. Williams, Chris Brew-Graves, Jonathan Deeks, Yemisi Takwoingi, Mark Emberton, and Caroline M. Moore |
| 264 | 1 | |c March 19, 2018 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.04.2020 | ||
| 520 | |a Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence is limited. | ||
| 700 | 1 | |a Hadaschik, Boris |d 1974- |e VerfasserIn |0 (DE-588)124300553 |0 (DE-627)085770930 |0 (DE-576)294109013 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 378(2018), Seite 1767-1777 |h Online-Ressource |w (DE-627)266889484 |w (DE-600)1468837-2 |w (DE-576)075962454 |x 1533-4406 |7 nnas |a MRI-targeted or standard biopsy for prostate-cancer diagnosis |
| 773 | 1 | 8 | |g volume:378 |g year:2018 |g pages:1767-1777 |g extent:11 |a MRI-targeted or standard biopsy for prostate-cancer diagnosis |
| 856 | 4 | 0 | |u https://doi.org/10.1056/NEJMoa1801993 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nejm.org/doi/10.1056/NEJMoa1801993 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200415 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 124300553 |a Hadaschik, Boris |m 124300553:Hadaschik, Boris |d 910000 |d 910200 |e 910000PH124300553 |e 910200PH124300553 |k 0/910000/ |k 1/910000/910200/ |p 22 | ||
| 999 | |a KXP-PPN1694604020 |e 3623917966 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Veeru Kasivisvanathan, Antti S. Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G. Hindley, Monique J. Roobol, Scott Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert M. Villeirs, Jaspal Virdi, Silvan Boxler, Grégoire Robert, Paras B. Singh, Wulphert Venderink, Boris A. Hadaschik, Alain Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter Pinto, Inderbir Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman R. Williams, Chris Brew-Graves, Jonathan Deeks, Yemisi Takwoingi, Mark Emberton, and Caroline M. Moore"]},"id":{"eki":["1694604020"],"doi":["10.1056/NEJMoa1801993"]},"recId":"1694604020","physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedDisp":"March 19, 2018","dateIssuedKey":"2018"}],"person":[{"display":"Kasivisvanathan, Veeru","family":"Kasivisvanathan","role":"aut","given":"Veeru"},{"family":"Hadaschik","role":"aut","given":"Boris","display":"Hadaschik, Boris"}],"relHost":[{"title":[{"title":"The New England journal of medicine","title_sort":"New England journal of medicine","subtitle":"NEJM"}],"note":["Gesehen am 04.08.25"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"1928-","dateIssuedKey":"1928","publisherPlace":"Waltham, Mass. ; Boston, Mass.","publisher":"MMS ; MMS"}],"disp":"MRI-targeted or standard biopsy for prostate-cancer diagnosisThe New England journal of medicine","recId":"266889484","physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2018","pages":"1767-1777","extent":"11","text":"378(2018), Seite 1767-1777","volume":"378"},"id":{"eki":["266889484"],"issn":["1533-4406"],"zdb":["1468837-2"]},"titleAlt":[{"title":"NEJM"}],"pubHistory":["198.1928 -"],"name":{"displayForm":["Massachusetts Medical Society"]},"corporate":[{"role":"isb","display":"Massachusetts Medical Society"}]}],"title":[{"title_sort":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 15.04.2020"]} | ||
| SRT | |a KASIVISVANMRITARGETE1920 | ||